Literature DB >> 25943967

Variation in the use of surveillance endomyocardial biopsy among pediatric heart transplant centers over time.

Justin Godown1, Michelle T Harris1, Judith Burger1, Debra A Dodd1.   

Abstract

EMB is widely utilized for graft surveillance after HTx; however, there is significant variation in the frequency of surveillance EMB use during the first year post-HTx. The aim of this study was to assess changes in the utilization of surveillance EMB over time among member institutions of PHTS. A survey of PHTS centers assessing the frequency of surveillance EMB use during the first year post-HTx was conducted in 2006. The same survey was repeated in 2014 to assess changes in practice over time. The number of EMB in infants ranged from 0 to 9 and in adolescents 0 to 16. The number of EMB decreased or remained unchanged in the majority of centers. Fewer EMB are performed in infants compared to adolescents and this practice did not change over time. There was a significant decrease in surveillance EMB use in adolescents (p = 0.012). International centers perform significantly fewer EMB in adolescents when compared to centers within the United States (p = 0.006). There continues to be significant variation in the utilization of surveillance EMB, with a shift toward less reliance on EMB for adolescents in the current era. Further research is necessary to determine the optimal frequency of invasive monitoring that reduces costs without compromising outcomes.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endomyocardial biopsy; heart transplantation; pediatric; rejection

Mesh:

Year:  2015        PMID: 25943967     DOI: 10.1111/petr.12518

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  10 in total

1.  Non-invasive detection of myocardial fibrosis in pediatric heart transplant recipients: The role of cardiovascular magnetic resonance.

Authors:  Jonathan H Soslow; Justin Godown
Journal:  Pediatr Transplant       Date:  2017-08

Review 2.  Pediatric heart transplantation: long-term outcomes.

Authors:  Anne I Dipchand; Jessica A Laks
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-05-29

3.  Reducing Fluoroscopic Radiation Exposure During Endomyocardial Biopsy in Pediatric Transplant Recipients.

Authors:  Jeffrey G Gossett; Christina L Sammet; Anya Agrawal; Karen Rychlik; David F Wax
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

4.  Decline in ventricular function as a result of general anesthesia in pediatric heart transplant recipients.

Authors:  Justin J Elhoff; Shahryar M Chowdhury; Carolyn L Taylor; Marc Hassid; Andrew J Savage; Andrew M Atz; Ryan J Butts
Journal:  Pediatr Transplant       Date:  2016-10-30

5.  Pediatric heart transplantation: advancing the field into the future.

Authors:  Justin Godown; Shawn C West
Journal:  Transl Pediatr       Date:  2019-10

Review 6.  Practice variability in pediatric heart transplantation: opportunities for collaboration.

Authors:  Aecha Marion Ybarra; Chesney Castleberry
Journal:  Transl Pediatr       Date:  2019-10

7.  Neonatal heart transplantation.

Authors:  Mohan John; Leonard L Bailey
Journal:  Ann Cardiothorac Surg       Date:  2018-01

Review 8.  Current state of pediatric cardiac transplantation.

Authors:  Anne I Dipchand
Journal:  Ann Cardiothorac Surg       Date:  2018-01

9.  Impact of routine surveillance biopsy intensity on the diagnosis of moderate to severe cellular rejection and survival after pediatric heart transplantation.

Authors:  Matthew D Zinn; Michael J Wallendorf; Kathleen E Simpson; Ashley D Osborne; James K Kirklin; Charles E Canter
Journal:  Pediatr Transplant       Date:  2018-01-29

10.  Center Variation in Hospital Costs for Pediatric Heart Transplantation: The Relationship Between Cost and Outcomes.

Authors:  Justin Godown; Cary Thurm; Matt Hall; Debra A Dodd; Brian Feingold; Jonathan H Soslow; Bret A Mettler; Andrew H Smith; David W Bearl; Kurt R Schumacher
Journal:  Pediatr Cardiol       Date:  2018-10-20       Impact factor: 1.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.